A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Doxacurium
Ormeloxifene
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Ormeloxifene.
Doxacurium
Lynestrenol
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Lynestrenol.
Doxacurium
Gestrinone
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gestrinone.
Doxacurium
Norgestrel
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Norgestrel.
Doxacurium
Norethynodrel
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Norethynodrel.
Doxacurium
Dienogest
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Dienogest.
Doxacurium
Gestodene
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gestodene.
Doxacurium
Cyproterone acetate
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Cyproterone acetate.
Doxacurium
Drospirenone
The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Drospirenone.
Doxacurium
Aluminum chloride
Aluminum chloride can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxacurium
Relcovaptan
The risk or severity of adverse effects can be increased when Relcovaptan is combined with Obeticholic acid.
Doxacurium
Buflomedil
The risk or severity of adverse effects can be increased when Buflomedil is combined with Obeticholic acid.
Doxacurium
Linsidomine
The risk or severity of adverse effects can be increased when Linsidomine is combined with Obeticholic acid.
Doxacurium
Cloricromen
The risk or severity of adverse effects can be increased when Cloricromen is combined with Obeticholic acid.
Doxacurium
Picotamide
The risk or severity of adverse effects can be increased when Picotamide is combined with Obeticholic acid.
Doxacurium
Ramatroban
The risk or severity of adverse effects can be increased when Ramatroban is combined with Obeticholic acid.
Doxacurium
Hydroxytyrosol
The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Obeticholic acid.
Doxacurium
Butylphthalide
The risk or severity of adverse effects can be increased when Butylphthalide is combined with Obeticholic acid.
Doxacurium
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Obeticholic acid.
Doxacurium
Ketanserin
The risk or severity of adverse effects can be increased when Ketanserin is combined with Obeticholic acid.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3